TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/12/18 16:45 | 7/10/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aisling Capital III LP | NY | T | S | -251,202 | 179.43 | 0 | -1,400 | -41 | 2,039 | D | |||||||||||||||
12/20/17 16:31 | 12/19/17 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aisling Capital III LP | NY | T | S | -20,125 | 80.50 | 0 | -250 | -7 | 3,439 | D | |||||||||||||||
11/27/17 19:29 | 11/22/17 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aisling Capital III LP | NY | T | S | -37,500 | 75.00 | 0 | -500 | -12 | 3,689 | D | |||||||||||||||
3/21/14 20:08 | 3/20/14 | DRTX | Durata Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aisling Capital III LP | NY | T | S.m | -1,584 | 15.74 | 0 | -101 | -3 | 3,030 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |